DETECT research study
Can cancer be detected through a simple blood test? Geisinger needs women ages 65-75 to help us answer this question.
What is DETECT?
Detecting Cancers Earlier Through Elective Mutation-Based Blood Collection and Testing (DETECT) is a research study that is trying to understand how well a blood test works for finding cancer. DETECT will use a research marker panel blood test to look for tumor DNA by checking for 16 genes and look for abnormally high levels of 11 protein markers.
Who is eligible to participate?
- Women between the ages of 65-75 years old
- No personal history of cancer
- If you had one of the following cancers, you may still be eligible:
- non-melanoma skin cancer
- squamous cell
- carcinoma in-situ
Will I benefit from participating in this study?
There may be no direct benefit to your being in this study. We do not yet know whether the test will help find cancer early. We hope that what is learned from this study will help others in the future.
How many people are you recruiting for DETECT?
- Enrollment target: 10,000 patients enrolled by December 31, 2018
- Current enrollment: 2,249 (updated February 12, 2018)
Where is this study taking place?
- Geisinger Bloomsburg Hospital, Professional Building (Bloomsburg, PA)
- Geisinger Medical Center (Danville, PA)
- Geisinger Precision Health Clinic (Forty-Fort, PA)
- Geisinger Grays Woods (Port Matilda, PA)
- Geisinger Mount Pleasant (Scranton, PA)
- Geisinger Mount Pocono (Mount Pocono, PA)
More sites are added regularly, please check back to see the list as it updates.
If I have more questions, who do I contact?
For more information about the study or if you'd like to participate, call the DETECT study team at 570-387-2154.